Abstract:Transdermal gene therapy is a useful treatment for many skin lesions. By penetrating stratum corneum directly, microneedle patch (MNP) has been widely investigated to improve transdermal gene delivery. However, considering the operability and patience compliance, quick gene release was required after insertion. In this research, by utilizing acidic cutaneous environment, pH-responsive polyelectrolyte multilayers (PEM) were coated on the surface of polycaprolactone (PCL) microneedles by layer-by-layer assembly to realize rapid gene release. Dimethylmaleic anhydride-modified polylysine (PLL-DMA), a charge reversible polymer, was introduced to PEM. The PEM composed of two parts: the transition layers of (PLL-DMA/polyethyleneimine)12 and the gene-loaded layers of (p53 expression plasmid/polyethyleneimine)16. Microneedle patch modified with such PEM was marked as tr-MNP. In following experiment, Hoechst 33258 dyed model DNA was used to track modification process, fluorescent intensity of tr-MNP was obviously strengthened while the number of bilayers increased and the morphology could be maintained. Each tr-MNP could load 31μg model DNA and improve gene release. To prove this character, MNP without transition layers (ntr-MNP) was fabricated as control. Tr-MNP could release 33% of model DNA in simulative cutaneous environment (phosphate buffer saline; pH=5.5) while ntr-MNP could only release 4%. That was because PLL-DMA could achieve charge reversal in acidic cutaneous environment, leading to the collapse of transition layers and promoted the gene release. In vivo experiment showed tumor inhibit efficacy of tr-MNP treated mice could reach 90.1% while that of ntr-MNP treated mice and intravenous administration mice was only 46.4% and 30.5%. Overall, the pH-responsive gene loaded MNP could treat subcutaneous tumor efficiently and showed potential to be a platform to load many biomacromolecule.

Enhancing Deep-Seated Melanoma Therapy Through Wearable Self-Powered Microneedle Patch

Integrated Therapeutic Strategies for Various Cutaneous Malignancies: Advances and Challenges of Multifunctional Microneedle Patches Toward Clinical Translation

Rapidly Dissolving Microneedle Patch for Synergistic Gene and Photothermal Therapy of Subcutaneous Tumor

Cutaneous Microenvironment Responsive Microneedle Patch for Rapid Gene Release to Treat Subdermal Tumor.

A responsive microneedle system for efficient anti-melanoma by combining self-enhanced chemodynamic therapy with photothermal therapy

Multifunctional Covalent Organic Framework-Based Microneedle Patch for Melanoma Treatment

Transdermal Delivery of Cu-doped Polydopamine Using Microneedles for Photothermal and Chemodynamic Synergistic Therapy Against Skin Melanoma

NIR Enhanced pH‐Responsive Microneedles for Synergetic Therapy of Melanoma

A novel multifunctional microneedle patch for synergistic photothermal- gas therapy against maxillofacial malignant melanoma and associated skin defects

A stimulus responsive microneedle-based drug delivery system for cancer therapy

Subcutaneous Rapid Dissolution Microneedle Patch Integrated with CuO2 and Disulfiram for Augmented Antimelanoma Efficacy through Multimodal Synergy of Photothermal Therapy, Chemodynamic Therapy, and Chemotherapy

Self-assembly Nanomicelle-Microneedle Patches with Enhanced Tumor Penetration for Superior Chemo-Photothermal Therapy

Photodynamic Bubble-Generating Microneedles for Enhanced Transdermal Cancer Therapy

Microneedle-mediated multifunctional nano-transdermal therapy system for in situ synergistic treatment of melanoma

Accelerated Cascade Melanoma Therapy using Enzyme-Nanozyme-Integrated Dissolvable Polymeric Microneedles

Microneedle-mediated treatment for superficial tumors by combining multiple strategies

Transdermal delivery of multifunctional CaO2@Mn-PDA nanoformulations by microneedles for NIR-induced synergistic therapy against skin melanoma

Double-layered microneedle patch loaded with bioinspired nano-vaccine for melanoma treatment and wound healing

Locoregional Melanoma Therapy by Tissue Adhesive Microneedle Patch-assisted Trans-tumoral Delivery of Anticancer Drug

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.